C5a receptor antagonist with therapeutic potential in endotoxic shock, ARDS Feb. 26, 1999 No Comments
Spotlight on double and triple enzyme inhibitors for treating cardiovascular disease Feb. 24, 1999 No Comments
Tissue factor inhibition: another mechanism linked to the cardiovascular effects of resveratrol Feb. 23, 1999 No Comments
AVI BioPharma presents data from preclinical study of Resten-NG in restenosis Feb. 22, 1999 No Comments
Renal protective effects of azelnidipine involve inhibition of AGE production Feb. 22, 1999 No Comments
RSS